Navigation Links
Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
Date:5/14/2008

HAYWARD, Calif., May 14 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) today announced that updated data will be presented on tanespimycin, the company's lead Hsp90 inhibitor, from a Phase 2 trial in combination with Herceptin(R) in patients with HER2-positive metastatic breast cancer, at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO), being held at McCormick Place, Chicago, IL, May 31 through June 3, 2008.

Abstract 1027, titled, "Phase 2 trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)," will be presented in a poster session in room E450a on Tuesday, June 3, 2008 from 8:00 am through 12:00 noon CT. The presenter is Shanu Modi, M.D., of Memorial Sloan-Kettering Cancer Center. This abstract will be highlighted in a poster discussion session to be held from 11:00 am - 12:00 noon CT in room E450b.

In addition, data from a Phase 1 trial of Kosan's Hsp90 inhibitor, alvespimycin, will be presented in an oral session on Monday, June 2, 2008 at 8:00 am to 11 am CT. Abstract 2502, titled, "First use of an oral Hsp90 inhibitor in patients (Pts) with solid tumors: Alvespimycin (A) administered QOD or QD," will be presented at 8:00 to 8:15 am CT in room W375a by Keith Flaherty, M.D., of the University of Pennsylvania.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development: Hsp90 (heat shock protein 90) inhibitors and epothilones. Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with V
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
6. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
7. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
8. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
9. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
(Date:1/14/2014)... 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System ... accompanying instrumentation to place and insert the screw accurately ... tissue (e.g. ligament) repair or reconstruction as it holds ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The ...
(Date:1/14/2014)... NineSigma , Inc., the leading innovation partner to organizations ... May 14-16, 2014 at the Global Center for Health ... This is the premier industry event for ... open innovation. Participants will learn how world-changing innovation is ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... Reportlinker.com announces that a new market ... Machine-to-Machine (M2M) Communications in ... http://www.reportlinker.com/p0498665/Machine-to-Machine-M2M-Communications-in-Healthcare-2010-20.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Healthcare "The market ... EUR69 billion in 2020. We expect that ...
... YORK, May 18, 2011 Reportlinker.com announces that ... its catalogue: Hong Kong SMBG ... http://www.reportlinker.com/p0497978/Hong-Kong-SMBG-Devices-and-Strips-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Navigation_Systems This Market Engineering ... dynamics of blood glucose monitoring device sales and ...
Cached Medicine Technology:Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20 2Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20 3Reportlinker Adds Hong Kong SMBG Devices and Strips Market 2Reportlinker Adds Hong Kong SMBG Devices and Strips Market 3Reportlinker Adds Hong Kong SMBG Devices and Strips Market 4Reportlinker Adds Hong Kong SMBG Devices and Strips Market 5Reportlinker Adds Hong Kong SMBG Devices and Strips Market 6
(Date:4/18/2014)... The Gerontologist reports that among older ... decrease in anxiety about death and increases in life ... In particular, listening to gospel music is associated with ... in sense of control. , These associations are similar ... of both low- and high-socioeconomic status. , The article, ...
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/17/2014)... inflammation in non-cancerous prostate tissue may have nearly twice ... with no inflammation, according to results of a new ... Cancer Center. , The link between persistent inflammation and ... prostate cancer those with a Gleason score between ... most aggressive and rapidly growing prostate cancers. , "What ...
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
(Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2
... HOUSTON, Dec. 3 Diabetes America (DA), the premier,network ... of Texas,announced today that they have partnered with Chevron ... an innovative new diabetes,management program. Patients or dependents over ... medical plan that are currently living with,diabetes are eligible ...
... Inc. (Amex: PLX ), noted today that ... which is used as,an enzyme replacement therapy for ... Promising Drugs Entering Phase III Trials in the ... published by Thomson Scientific. Thomson,Scientific, a part of ...
... Sites, DENVER, Dec. 3 Global ... international e-Health, medical,information technology company, today announced ... agreement to license its transfusion,management system SafeTrace ... Sheridan Memorial Hospital (Sheridan) joins a growing,customer ...
... Ohio, Dec. 3 Low income families and,uninsured ... brand-name,medications for only $7 per prescription per month ... Prescription Hope is offering this new prescription assistance ... Medicaid or those that have,prescription coverage, according to ...
... Health Can Prevent High Heel Hangover, SALEM, N.H., Dec. ... you feel after a day or night in heels. The ... hangover can be,eliminated from your life, without having to give ... "shoe addicts" but they don,t think about,how the shoes they ...
... Dec. 3 (Pink Sheets: HRAL),HearAtLast Holdings, Inc. ... Gretzky, and HearAtLast president Robert Oswald will be,featured ... Monday, December 3,2007. These interviews and features are ... the 15th HearAtLast clinic that will be co-located ...
Cached Medicine News:Health News:Diabetes America Teams Up with Chevron Phillips Chemical for an Innovative Diabetes Management Program 2Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 2Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 3Health News:Global Med Technologies(R), Inc. Adds Wyoming Hospital to Growing Customer Base 2Health News:Global Med Technologies(R), Inc. Adds Wyoming Hospital to Growing Customer Base 3Health News:$7 Brand Name Prescriptions for Low Income and Un-Insured Avoid Prescription Discount Cards! 2Health News:High Heel Health 2Health News:HearAtLast Spokesperson Walter Gretzky and President Robert Oswald to be Featured on Three TV Segments in Conjunction with Ottawa Store Opening 2Health News:HearAtLast Spokesperson Walter Gretzky and President Robert Oswald to be Featured on Three TV Segments in Conjunction with Ottawa Store Opening 3
... Esteem™ External Vacuum Therapy System restores sexual ... men. Non-invasive and low cost vacuum therapy, ... desirable outcome", makes it the ideal therapy ... Therapy System causes penile rigidity that can ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
... an advanced ophthalmic system that integrates ... allowing surgeons to independently select either ... procedures.,The key feature of this futuristic ... that measures in-line vacuum pressure, ensuring ...
... The D.O.R.C. Harmony Total TTC® is a ... and vitreoretinal surgery. Color coded function modes ... a compact design assures an easy to ... dual linear function footswitch provides the surgeon ...
Medicine Products: